
Sign up to save your podcasts
Or


Pfizer on Monday announced that its COVID-19 vaccine has proven effective in preventing infection in over 90% of Phase 3 clinical trial patients, and added that it could have 50 million doses available by year-end. Dan talks to Pfizer CEO Albert Bourla about data, distribution, politics, and how he reacted upon receiving the news.
By Axios4.3
689689 ratings
Pfizer on Monday announced that its COVID-19 vaccine has proven effective in preventing infection in over 90% of Phase 3 clinical trial patients, and added that it could have 50 million doses available by year-end. Dan talks to Pfizer CEO Albert Bourla about data, distribution, politics, and how he reacted upon receiving the news.

7,669 Listeners

37,093 Listeners

1,355 Listeners

1,062 Listeners

9,531 Listeners

1,514 Listeners

2,010 Listeners

87,218 Listeners

32,314 Listeners

2,139 Listeners

255 Listeners

12,519 Listeners

2,021 Listeners

4,365 Listeners

15,942 Listeners

10,623 Listeners

3,535 Listeners